Bayer AG (0P6S)
LSE
Closed
Oct 7, 2026
Day's Range
43.7252 wk Range
25.79Overview - 0P6S - Bayer AG
Key Statistics
Valuation
Enterprise Value
62.68B
P/E (Trailing)
‪19.01‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪1.02‬
Price / Book
‪1.48‬
EV / EBITDA
‪5.53‬
Profitability
Gross Margin
‪58.24%‬
Profit Margin
‪-6.17%‬
Operating Margin
‪16.37%‬
Return on Assets
‪4.04%‬
Return on Equity
‪-8.17%‬
Ownership
Shares Outstanding
982.42M
Float
982.31M
Held by Insiders
‪0.02%‬
Held by Institutions
‪49.03%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪48.50‬
200-Day Avg
‪42.67‬
Market Cap - 0P6S - Bayer AG
Peers - 0P6S - Bayer AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0P6SLSEBayer AG48.99BMarket Cap+44.73%52-week change19.01P/E (Trailing)‪-6.17%‬Profit Margin
- AZNLSEAstraZeneca PLC19.27TMarket Cap+9.73%52-week change24.57P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.52TMarket Cap+19.52%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
Profile Summary - 0P6S - Bayer AG
About
Bayer AG is a German life sciences company focused on healthcare and agriculture. Its business is organized around Pharmaceuticals, Consumer Health, and Crop Science, combining prescription medicines, over-the-counter products, seeds, crop protection, and related agricultural solutions. In pharmaceuticals, Bayer…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
